Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / AVITA Medical Investor Webinar Briefing
Business Investor briefing

AVITA Medical Investor Webinar Briefing

Analysis based on 6 articles · First reported Aug 09, 2026 · Last updated Aug 09, 2026

Sentiment
0
Attention
0
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The investor webinar is a routine communication event with minimal direct market impact. It may provide additional color on AVITA Medical's Q2 2026 results, potentially influencing investor sentiment modestly.

Medical Devices
Event Summary

AVITA Medical, Inc. (Nasdaq: RCEL, ASX: AVH), a therapeutic acute wound care company, announced it will host an investor webinar briefing on August 12, 2026, at 4:00 p.m. Pacific Time. The presentation, led by President and CEO Cary Vance and CFO David O Toole, will cover financial and business results from the company's recent second-quarter 2026 earnings webcast, followed by a Q&A session. The webinar is open to shareholders and prospective investors, with registration via Zoom and a replay available on the company's website. AVITA Medical's platform includes RECELL, an FDA-approved device for thermal burn and trauma wounds, and it holds exclusive rights to distribute Cohealyx and PermeaDerm in the U.S. Internationally, RECELL is approved in Europe, Australia, New Zealand, and Japan.

Entities Involved
stock
AVITA Medical
Host company of the webinar; the event is a routine investor communication with no material change in business operations.
Importance 100.0 Sentiment 0.0
per
Cary Vance
President and CEO, will present at the webinar; his role is to communicate results and strategy.
Importance 60.0 Sentiment 0.0
per
David O Toole
Chief Financial Officer, will present financial results; his role is to provide financial details.
Importance 50.0 Sentiment 0.0
govactor
United States — Food and Drug Administration
Regulator that approved RECELL; mentioned as part of company background, no new regulatory action.
Importance 30.0 Sentiment 0.0
exch
Nasdaq
Exchange where AVITA Medical is listed; no direct impact from this event.
Importance 20.0 Sentiment 0.0
cnt
United States
Market where AVITA Medical operates; no direct impact from this event.
Importance 20.0 Sentiment 0.0
exch
Australian Securities Exchange
Exchange where AVITA Medical is listed; no direct impact from this event.
Importance 20.0 Sentiment 0.0
cnt
Australia
Market where RECELL has TGA certification; no direct impact from this event.
Importance 20.0 Sentiment 0.0
cnt
Japan
Market where RECELL is PMDA-approved; no direct impact from this event.
Importance 15.0 Sentiment 0.0
cnt
New Zealand
Market where RECELL is listed with Medsafe; no direct impact from this event.
Importance 15.0 Sentiment 0.0
loc
Europe
Market where RECELL is CE-marked; no direct impact from this event.
Importance 15.0 Sentiment 0.0
priv
Stedical Scientific
Owner of PermeaDerm trademark; mentioned as background, no direct impact from this event.
Importance 10.0 Sentiment 0.0
Relationships
United States — Food and Drug Administration related ↔ Nasdaq
United States — Food and Drug Administration related ↔ United States
United States — Food and Drug Administration related ↔ Australia
United States — Food and Drug Administration related ↔ Japan
Nasdaq related ↔ United States
Nasdaq related ↔ Australian Securities Exchange
Nasdaq related ↔ Australia
Nasdaq related ↔ Japan
United States related ↔ Australia
United States ally ↔ Japan The United States considers Japan a cornerstone defense ally and a vital economic partner in the Indo-Pacific, with exte
United States related ↔ New Zealand
Australian Securities Exchange related ↔ Australia
Australia related ↔ Japan
Australia allies ↔ New Zealand Australia views New Zealand as a deeply integrated and strategic ally, sharing strong historical, cultural, economic, an
Japan related ↔ New Zealand
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.